Cargando…

Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement

INTRODUCTION: Pregnancy is a time of increased healthcare screening, and past adherence to evolving guidelines informs best practices. Although studies of Group B Streptococcus guideline adherence have focused primarily on treatment of Group B Streptococcus carriers, this study broadly evaluated lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Santillan, Donna A., Hubb, Alexander J., Nishimura, Taryn E., Rosenfeld-O'Tool, Sandra R., Schroeder, Kathleen J., Conklin, Jona M., Karras, Alexandra E., Gumusoglu, Serena B., Brandt, Debra S., Miller, Emily, Hunter, Stephen K., Santillan, Mark K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546507/
https://www.ncbi.nlm.nih.gov/pubmed/37791233
http://dx.doi.org/10.1016/j.focus.2022.100028
_version_ 1785114876175187968
author Santillan, Donna A.
Hubb, Alexander J.
Nishimura, Taryn E.
Rosenfeld-O'Tool, Sandra R.
Schroeder, Kathleen J.
Conklin, Jona M.
Karras, Alexandra E.
Gumusoglu, Serena B.
Brandt, Debra S.
Miller, Emily
Hunter, Stephen K.
Santillan, Mark K.
author_facet Santillan, Donna A.
Hubb, Alexander J.
Nishimura, Taryn E.
Rosenfeld-O'Tool, Sandra R.
Schroeder, Kathleen J.
Conklin, Jona M.
Karras, Alexandra E.
Gumusoglu, Serena B.
Brandt, Debra S.
Miller, Emily
Hunter, Stephen K.
Santillan, Mark K.
author_sort Santillan, Donna A.
collection PubMed
description INTRODUCTION: Pregnancy is a time of increased healthcare screening, and past adherence to evolving guidelines informs best practices. Although studies of Group B Streptococcus guideline adherence have focused primarily on treatment of Group B Streptococcus carriers, this study broadly evaluated long-term adherence to both Group B Streptococcus screening and treatment guidelines. Adherence was evaluated across provider types (obstetrics and gynecology, certified nurse midwives, and family medicine). METHODS: We conducted a retrospective cohort study. Demographic and clinical information were extracted from all prenatal care and delivery patients at a single institution in a single year. Vancomycin prescriptions in pregnancy were tracked for 10 years to determine long-term adherence. Adherence was defined as no deviation from 2010 Group B Streptococcus screening and treatment guidelines. RESULTS: Adherence occurred in 89% (1,610/1,810) of patients. Reasons for deviations from guidelines could not always be determined. There was no significant difference in maternal age, race, prenatal provider type, provider type at delivery, gestational age at delivery, delivery mode, or whether antibiotic sensitivities were performed between compliant and noncompliant groups. Significant differences in adherence were found between obstetric clinics (high-risk obstetrics clinic, maternal‒fetal medicine fellows clinic, continuity of care clinic, and faculty private clinic) (p<0.0001) and between the faculty family medicine clinic and resident family medicine clinic (p=0.001). Vancomycin prescription practice did not change significantly over the10-year period. CONCLUSIONS: High rates of adherence to Group B Streptococcus screening and treatment guidelines in pregnancy have positive implications for reducing antibiotic resistance. Given evolving guidelines, there is a need to periodically evaluate adherence and to re-educate providers about standard practices and best documentation practices.
format Online
Article
Text
id pubmed-10546507
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105465072023-10-03 Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement Santillan, Donna A. Hubb, Alexander J. Nishimura, Taryn E. Rosenfeld-O'Tool, Sandra R. Schroeder, Kathleen J. Conklin, Jona M. Karras, Alexandra E. Gumusoglu, Serena B. Brandt, Debra S. Miller, Emily Hunter, Stephen K. Santillan, Mark K. AJPM Focus Research Article INTRODUCTION: Pregnancy is a time of increased healthcare screening, and past adherence to evolving guidelines informs best practices. Although studies of Group B Streptococcus guideline adherence have focused primarily on treatment of Group B Streptococcus carriers, this study broadly evaluated long-term adherence to both Group B Streptococcus screening and treatment guidelines. Adherence was evaluated across provider types (obstetrics and gynecology, certified nurse midwives, and family medicine). METHODS: We conducted a retrospective cohort study. Demographic and clinical information were extracted from all prenatal care and delivery patients at a single institution in a single year. Vancomycin prescriptions in pregnancy were tracked for 10 years to determine long-term adherence. Adherence was defined as no deviation from 2010 Group B Streptococcus screening and treatment guidelines. RESULTS: Adherence occurred in 89% (1,610/1,810) of patients. Reasons for deviations from guidelines could not always be determined. There was no significant difference in maternal age, race, prenatal provider type, provider type at delivery, gestational age at delivery, delivery mode, or whether antibiotic sensitivities were performed between compliant and noncompliant groups. Significant differences in adherence were found between obstetric clinics (high-risk obstetrics clinic, maternal‒fetal medicine fellows clinic, continuity of care clinic, and faculty private clinic) (p<0.0001) and between the faculty family medicine clinic and resident family medicine clinic (p=0.001). Vancomycin prescription practice did not change significantly over the10-year period. CONCLUSIONS: High rates of adherence to Group B Streptococcus screening and treatment guidelines in pregnancy have positive implications for reducing antibiotic resistance. Given evolving guidelines, there is a need to periodically evaluate adherence and to re-educate providers about standard practices and best documentation practices. Elsevier 2022-08-28 /pmc/articles/PMC10546507/ /pubmed/37791233 http://dx.doi.org/10.1016/j.focus.2022.100028 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Santillan, Donna A.
Hubb, Alexander J.
Nishimura, Taryn E.
Rosenfeld-O'Tool, Sandra R.
Schroeder, Kathleen J.
Conklin, Jona M.
Karras, Alexandra E.
Gumusoglu, Serena B.
Brandt, Debra S.
Miller, Emily
Hunter, Stephen K.
Santillan, Mark K.
Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement
title Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement
title_full Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement
title_fullStr Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement
title_full_unstemmed Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement
title_short Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for Improvement
title_sort group b streptococcus screening and treatment adherence in pregnancy: a retrospective cohort study and opportunities for improvement
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546507/
https://www.ncbi.nlm.nih.gov/pubmed/37791233
http://dx.doi.org/10.1016/j.focus.2022.100028
work_keys_str_mv AT santillandonnaa groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT hubbalexanderj groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT nishimurataryne groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT rosenfeldotoolsandrar groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT schroederkathleenj groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT conklinjonam groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT karrasalexandrae groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT gumusogluserenab groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT brandtdebras groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT milleremily groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT hunterstephenk groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement
AT santillanmarkk groupbstreptococcusscreeningandtreatmentadherenceinpregnancyaretrospectivecohortstudyandopportunitiesforimprovement